Hong Kong Island. Kowloon!

In a high-rise office building on Jordan Road, a far-reaching negotiation is in full swing.

The identities of the two parties in the negotiation are very different. One party is Hong Kong Yuanwei Pharmaceutical, a small company that has just been established for a short time, and the other party is Johnson & Johnson Biological Group, the most powerful pharmaceutical company in China.

The content of their negotiations was about the patent authorization of fluoxetine!

The negotiations have been going on for more than two hours, but the two sides have never been able to reach an agreement on the core issues.

"Mr. Yan, if you think the price of 18 million US dollars is lower than expected, we can add another 2 million. How about 20 million?"

From the main seat on the left, Yan Gengdong said calmly: "Mr. Bok, you know, this is not about money!"

"What is that?"

"Mr. Polk, let me reiterate our company's point of view. We will not sell the patent on fluoxetine. If your company wants to cooperate with us, please give up this idea."

"Mr. Yan, 20 million US dollars is already a lot of money. It can buy several small companies like yours, can't it?"

"Haha, if the company doesn't have good products, it really won't be worth much, but our Yuanwei Medicine is obviously not such a company, so please put aside your sense of superiority, Mr. Bok!" Yan Gengdong said.

Bok frowned and said: "Mr. Yan, you should also know the strength of our Johnson & Johnson company. Without our nod, it would be impossible for your drug to pass the review and enter the North American market!"

Yan Gengdong smiled and said: "I have never doubted your company's strength, but if this is your company's sincerity in cooperation, then please come back!"

"Mr. Yan, do you really want to reject our Johnson & Johnson Group?" Bo Ke stared at Yan Gengdong and asked.

"It's not that I want to reject your company, but that your company has no sincerity in cooperation!"

Then Yan Gengdong said with a mocking look: "You want to buy out the patent rights of fluoxetine in North America for US$20 million. Your company is not cooperating at all, but joking with us!"

"Mr. Yan, as far as I know, the performance of your drug in the local market of Hong Kong Island is not very good. If you insist on developing it yourself, you may not be able to earn 20 million US dollars." Bo Ke said.

Yan Gengdong glanced at him and said calmly: "Mr. Polk, where did you hear that the market performance of fluoxetine is not good? Do you know what the sales volume of fluoxetine was in Asia last month?"

"This... I'm not sure!"

Yan Gengdong glanced at the sales manager next to him, and then said: "Manager Xiao, tell Mr. Bok about our company's sales performance last month!"

Xiao Wenyuan immediately said: "Mr. Polk, last month the local (Hong Kong Island) sales team achieved a total of 1.67 million US dollars in sales, the Bay Island team achieved 1.88 million US dollars, the Australian Island team achieved 590,000 US dollars, and the South Korean team achieved 2.89 million US dollars.

5.82 million from Xiaozhi, plus the Southeast Asian market that is being developed, our company's revenue last month reached 12.8 million!"

Hearing Xiao Wenyuan's words, Bo Ke was stunned.

The negotiations between them and Yuanwei Pharmaceutical have been going on for more than half a month, and they have already investigated the situation of this company.

The company has only been established for half a year. Although the company's independently developed fluoxetine has good efficacy in treating depression and anorexia nervosa, it has not been tested by the market. Therefore, whether this drug can be used

Market acceptance is still unknown.

It is precisely because of this that they offered a price of 20 million US dollars to buy out the patent authorization of the drug in North America.

But I didn't expect that the market performance of this kind of drug would be so good. In Asia alone, the monthly revenue reached more than 10 million US dollars.

Judging by the profits of the pharmaceutical industry, last month alone, the drug brought a net profit of more than 8 million yuan to this small company. No wonder the other party is so determined!

What's more important is that the market response to this drug is so good now that it can be expected that profits will only get higher and higher in the future.

By then, other domestic pharmaceutical companies may also be interested in this drug, which makes Bok feel a little pressure.

At this time, Yan Gengdong said again: "Mr. Polk, we just reached an agreement with Ruiying Pharmaceuticals in Europe this month to jointly produce and sell fluoxetine. As expected, fluoxetine will be available in Europe soon."

"As for North America, even if we don't cooperate with your company, we can still enter the North American market. After all, in addition to Johnson & Johnson, Pfizer and Eli Lilly are also very interested in our drug!"

Polk knew that they had missed the best opportunity to acquire the patent for this drug at a low price, and Plan A had completely failed.

Fortunately, they also formulated a plan B!

At that moment, he immediately adjusted his mood, and then said: "Since Mr. Yan is unwilling to sell the patent rights of fluoxetine, we will not force it, but we, Johnson & Johnson, want those exclusive agency rights in North America!"

"This can be discussed, but the annual agency fee cannot be less than 50 million US dollars, and we also need 20% of the sales profit!" Yan Gengdong said.

"50 million is too much. The most we can offer is 15 million. The other 20% of the sales profit has exceeded the normal drug sharing limit, which is 10% at most!"

"We each take a step back, 40 million agency fees plus 18% sales share!"

"20 million, 12%..."

"35 million, 17%..."

After some haggling, the two parties finally reached an agreement with an agency fee of 25 million yuan plus a 15% sales share!

After sending Bock away, Yan Gengdong met with representatives of Otsuka Pharmaceuticals again and continued to negotiate with them on the sales and promotion of fluoxetine.

At six o'clock in the evening, after seeing off the last batch of guests, Yan Gengdong returned to his residence on the top floor of the company.

After making sure that the surrounding environment was safe, he took out a small radio from the secret safe and started operating it in the house.

Soon, a top-secret telegram was sent by him!

After putting away the radio, Yan Gengdong came to the window, looked at the flashing neon lights outside, and silently lit a cigarette.

Counting today, it has been almost four months since he came to Hong Kong Island!

During these four months, he took advantage of the convenient conditions provided by the Ministry of Commerce and quickly took over Weiyuan Pharmaceutical Company.

Although this company was established by people from the Ministry of Commerce, in order to keep it confidential, apart from the staff who originally established the company, only Yan Gengdong was sent from China.

The rest, ranging from managers and supervisors in the company to receptionists, clerks and even cleaners, are all ordinary people recruited locally.

There is no way. If people know that this company has a background in mainland China, it will not be easy to do business with Western countries.

Even in order to prevent others from suspecting his identity, when Yan Gengdong entered Hong Kong Island, he took advantage of Siam and acquired Weiyuan Company as a Thai-Chinese.

After taking over the company, Yan Gengdong carried out all-round promotion of fluoxetine according to the promotion plan given to him by Zhou Yang.

In the first month, the company only conducted business on Hong Kong Island, with revenue of less than HK$500,000.

In the second month, the business expanded to surrounding Bay Islands and Ao Islands, and revenue increased to HK$3 million.

In the third month, fluoxetine was recognized by patients due to its good efficacy and reliable properties, and its reputation skyrocketed. He took this opportunity to send a team to cooperate with pharmaceutical companies in South Korea, Xiaori and other countries, and his sales skyrocketed.

At present, the company has created nearly 10 million U.S. dollars in profits, and today it has signed cooperation agreements with Johnson & Johnson Group and Otsuka Pharmaceuticals, and has once again received nearly 30 million U.S. dollars in agency fees.

As a result, the company's profits have exceeded 40 million US dollars, far exceeding the domestic tasks.

The company's development has been on the right track and it has achieved certain results. Yan Gengdong decided to spread the good news back to China!

But what Yan Gengdong didn't know was that after his telegram was sent to China, it quickly caused a sensation among senior officials!
Chapter completed!